Sphera Funds Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Sphera Funds Management’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-136,656	Closed	-$6M	–	161
2021 Q2	$6M	Hold	136,656	–	–	0.41%	67
2021 Q1	$9.92M	Buy	+136,656	New	+$9.71M	0.76%	30
2019 Q3	–	Sell	-10,743	Closed	-$1.5M	–	108
2019 Q2	$1.5M	Sell	10,743 -9,036	-46%	-$1.59M	0.21%	75
2019 Q1	$3.54M	Sell	19,779 -17,221	-47%	-$2.59M	0.32%	72
2018 Q4	$5.82M	Buy	+37,000	New	+$5.52M	0.66%	35

Other funds holding ORTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Sphera Funds Management's ORTX Position: Q3 2021 in Review

Sphera Funds Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2021, closing a stake of 136,656 shares — an estimated $6M sold.

Sphera Funds Management first reported a position in ORTX in Q4 2018 and held it in 5 quarters. The position peaked at $9.92M in Q1 2021. 79 funds tracked by Wall St. Rank hold ORTX as of Q3 2021.

Sphera Funds Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2021 after selling out during the quarter.
Sphera Funds Management sold 136,656 Orchard Therapeutics plc American Depositary Shares shares in Q3 2021, an estimated $6M.
Sphera Funds Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 5 quarters.
Sphera Funds Management's Orchard Therapeutics plc American Depositary Shares position peaked at $9.92M in Q1 2021.
79 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2021.

Based on Sphera Funds Management's 13F filing for Q3 2021, filed 15 Nov 2021.